Publications by authors named "Amber Weller"

Claim this Profile
T
The Addition of Fish Oil to Cognitive Behavioral Case Management for Youth Depression: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial.
G Paul Amminger, Simon Rice, Christopher G Davey, Amelia L Quinn, Daniel F Hermens, Amber Weller

Biol Psychiatry· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Study of Ketamine for Youth Depression (SKY-D): study protocol for a randomised controlled trial of low-dose ketamine for young people with major depressive disorder.
Orli S Schwartz, Paul Amminger, Bernard T Baune, Gillinder Bedi, Michael Berk, Amber Weller

Trials· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cannabidiol for at risk for psychosis youth: A randomized controlled trial.
G Paul Amminger, Ashleigh Lin, Melissa Kerr, Amber Weller, Jessica Spark

Early Interv Psychiatry· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discontinuation of antipsychotic medication-time to rethink trial design.
Helene Speyer, Marieke Begemann, Nikolai Albert, Amber Weller, Merete Nordentoft

Lancet Psychiatry· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Y
Youth Depression Alleviation with Anti-inflammatory Agents (YoDA-A): a randomised clinical trial of rosuvastatin and aspirin.
Michael Berk, Mohammadreza Mohebbi, Olivia M Dean, Sue M Cotton, Andrew M Chanen, Amber Weller

BMC Med· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can antipsychotic dose reduction lead to better functional recovery in first-episode psychosis? A randomized controlled-trial of antipsychotic dose reduction. The reduce trial: Study protocol.
Amber Weller, John Gleeson, Mario Alvarez-Jimenez, Patrick McGorry, Barnaby Nelson

Early Interv Psychiatry· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The addition of fluoxetine to cognitive behavioural therapy for youth depression (YoDA-C): a randomised, double-blind, placebo-controlled, multicentre clinical trial.
Christopher G Davey, Andrew M Chanen, Sarah E Hetrick, Sue M Cotton, Aswin Ratheesh, Amber Weller

Lancet Psychiatry· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis